Europe News
Most Popular Europe Story
UCB CEO plots strategy following Cimzia approval
Fresh off the FDA's approval of Cimzia for Crohn's disease, UCB chief executive Roch Doliveux forecast a swift regulatory success in Europe. Cimzia is one of the most closely watched late-stage... Read more...
Latest Headlines
- October 7, 2008
- May 13, 2008
- April 24, 2008
- April 15, 2008
- April 7, 2008
- February 15, 2008
- February 4, 2008
- January 17, 2008
- December 20, 2007
- November 27, 2007
- November 19, 2007
- November 6, 2007
- October 26, 2007
- October 25, 2007
- October 8, 2007
- September 17, 2007
- August 30, 2007
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
